Black Health

Sickle Cell · Topic guide

Sickle Cell Pain Crisis in the ER — How to Advocate for Proper Treatment

Sickle cell pain crises are routinely undertreated in emergency departments: Black patients with SCD wait longer for analgesia and are more often suspected of drug-seeking behavior than white patients with comparable pain — documented in Haywood et al., Lazio et al., and Glassberg.

Body

What NHLBI and ASH guidelines say

The NHLBI 2014 expert-panel report on SCD management and the ASH 2020 Clinical Practice Guidelines both state that for an SCD patient presenting to the emergency department with a vaso-occlusive crisis, the first dose of parenteral analgesic should be given within 30 minutes of triage and within 60 minutes of registration. Pain reassessment should happen every 15-30 minutes, with additional dosing until pain is controlled.

What the observational data show

Multiple published studies — Haywood et al. in the Journal of General Internal Medicine (2010, 2013), Glassberg et al. in Annals of Emergency Medicine (2013), Lazio et al. (2010), and Tanabe et al. — document that in practice, Black adult SCD patients wait a median of 60-90 minutes for a first analgesic dose, and are more likely than patients with comparable-severity pain to be assessed as drug-seeking. The guideline-practice gap is not a matter of dispute.

What reduces the wait

The single most effective intervention is a written pain plan from your hematologist, carried with you to every ED visit. A pain plan specifies:

  • Your name, hemoglobin genotype, and baseline crisis pattern
  • The specific opioid regimen that has worked for you (drug, dose, route, frequency)
  • Your hematologist's name and direct phone number for the ED to call
  • A statement that you are known to your hematologist's clinic and that this is a chronic inherited disease, not opioid-seeking behavior

Every comprehensive SCD center listed on this site will supply a pain plan on request. Ask for one at your next hematology appointment.

Your rights under EMTALA

Under the Emergency Medical Treatment and Active Labor Act (EMTALA, 42 USC 1395dd), any Medicare-participating hospital with an emergency department must provide a medical screening examination and stabilizing treatment to any patient presenting with an emergency medical condition — regardless of insurance status. A sickle cell pain crisis qualifies. You cannot be transferred or discharged until your pain is stabilized or you give informed consent to transfer. Refusals can be reported to the HHS Office of Inspector General.

What to say if the ED is not treating your crisis

If your pain is not being treated: ask (in writing if possible) for (1) the attending physician's name, (2) the charge nurse's name, and (3) a copy of the hospital's SCD pain protocol. Then call your hematologist's on-call number and ask them to speak with the ED attending directly. If the hospital still does not treat your pain, file a complaint with the state's Department of Health and with the HHS Office for Civil Rights.

For Black families

The evidence that Black patients with SCD are undertreated for pain in the ER is not contested — it is replicated across Haywood et al. (JGIM 2010, J Natl Med Assoc 2013), Glassberg et al. (Ann Emerg Med 2013), Lazio et al. (Ann Emerg Med 2010), and the NHLBI's 2014 SCD management guidelines. The guideline-recommended time-to-first-analgesic-dose for an SCD pain crisis is under 30 minutes from triage; observational studies document median wait times of 60-90 minutes for Black SCD patients. What shortens the wait: a written pain plan signed by the patient's hematologist, brought to every ED visit. Every comprehensive center on this site supplies one.

More sickle cell topics

Comprehensive centers

What a Sickle Cell Comprehensive Care Center Actually Is — and How to Find One

Newborn screening

Sickle Cell Newborn Screening — Every State Screens, What Happens Next

Treatments

Sickle Cell Disease Treatments — Hydroxyurea to CRISPR Gene Therapy

Adult transition

The Sickle Cell Adolescent-to-Adult Transition — Where Mortality Peaks

Clinical trials

Active Sickle Cell Clinical Trials Recruiting Black Patients

References

  • NHLBI, "Evidence-Based Management of Sickle Cell Disease" (2014 expert panel report): nhlbi.nih.gov.
  • American Society of Hematology 2020 SCD Clinical Practice Guidelines: hematology.org.
  • CDC Sickle Cell Data Collection program: cdc.gov/ncbddd/hemoglobinopathies/scdc.
  • Sickle Cell Disease Association of America: sicklecelldisease.org.
  • Haywood C et al., "A systematic review of barriers and interventions to improve appropriate use of therapies for SCD" (JGIM 2010, 2013).
  • Glassberg J et al., "Race and Gender Disparities in Emergency Department Triage Acuity for Sickle Cell Disease" (Ann Emerg Med 2013).

Last updated: